title: Primary cardiac lymphoma: utility of multimodality imaging in diagnosis and management.
abstract: Primary cardiac lymphoma (PCL) is an extremely rare disease defined as a lymphoma strictly confined to the heart or pericardium without dissemination. We present the case of an 82 yr old male with newly diagnosed PCL and two years of subsequent follow up. This report highlights the utility of a multimodality imaging approach in the diagnosis and management of PCL.
authors: Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. anthony.mato@uphs.upenn.edu
authors: Anthony R
authors: AR
authors: Mato
authors: Alicia K
authors: AK
authors: Morgans
authors: Michele R
authors: MR
authors: Roullet
authors: Adam
authors: A
authors: Bagg
authors: Eli
authors: E
authors: Glatstein
authors: Harold I
authors: HI
authors: Litt
authors: Lisa H
authors: LH
authors: Downs
authors: Elise A
authors: EA
authors: Chong
authors: Erin R
authors: ER
authors: Olson
authors: Charalambos
authors: C
authors: Andreadis
authors: Stephen J
authors: SJ
authors: Schuster
mesh_terms: D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D015703:Antigens, CD / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003952:Diagnostic Imaging / Q000379:methods*; D019468:Disease Management; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D004452:Echocardiography; D006338:Heart Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced; D016403:Lymphoma, Large B-Cell, Diffuse / Q000737:chemistry / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D008279:Magnetic Resonance Imaging; D008297:Male; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012074:Remission Induction; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D015703:Antigens, CD; D014408:Biomarkers, Tumor; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone